A detailed history of Harbour Investments, Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 265 shares of VNDA stock, worth $1,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
265
Previous 265 -0.0%
Holding current value
$1,240
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$15.69 - $21.14 $36,965 - $49,805
-2,356 Reduced 89.89%
265 $4,000
Q3 2021

Nov 15, 2021

BUY
$15.35 - $21.27 $706 - $978
46 Added 1.79%
2,621 $45,000
Q2 2021

Aug 16, 2021

BUY
$15.71 - $21.51 $5,184 - $7,098
330 Added 14.7%
2,575 $55,000
Q1 2021

Aug 17, 2021

BUY
$13.42 - $20.28 $30,127 - $45,528
2,245 New
2,245 $34,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $265M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.